Drug · DIN 02549689
AG-SUMATRIPTAN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since July 11, 2024.
- Drug Identification Number (DIN)
- 02549689
- Company (DIN owner)
- Angita Pharma Inc.Boucherville, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sumatriptan N02CC01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUMATRIPTAN (SUMATRIPTAN SUCCINATE) | 25 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- July 11, 2024: NOC 33612Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement between two manufacturers
Other DINs named AG-SUMATRIPTAN
- DIN 02549697 · Approved
- DIN 02549700 · Approved